Leukaemia

Acute Leukaemia

How I Treat Refractory Ph-ve A.L.L

Visit site

Curative Potential of RIC in AML

Visit site

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Visit site

How I Treat Myelofibrosis

Visit site

BCSH guideline update for essential thrombocythaemia

Visit site

Revised International Prognostic Scoring System for MDS

Visit site

Pre transplant MRD in AML

Visit site

How I Treat APML

Visit site

How I Treat Haematological Emergencies in Adult Leukaemia

Visit site

How I Treat Plasma Cell Leukaemia

Visit site

How We Treat Lower Risk MDS

Visit site

How We Treat Higher Risk MDS

Visit site

How I Treat Leukaemia During Pregnancy

Visit site

How I treat older patients with ALL

Visit site

Diagnosis and Treatment of MDS

Visit site

Diagnosis and Management of AML in adults

Visit site

Diagnosis and Management of Myelofibrosis

Visit site

Chronic Leukaemia

CLL transplant or novel agent

Visit site

Early DLI in molecular relapse post allograft. EBMT Working Party

Visit site

Managing children with CML (up to age 18)

Visit site

Prognostic score for CLL

Visit site

How I Treat CML Blast Crisis

Visit site

How I Treat Newly Diagnosed Chronic Phase CML

Visit site

ELN recommendations for management of CML 2013

Visit site

Guidelines for diagnosis and management of hairy cell leukaemia

Visit site

Guidelines for diagnosis, investigation and management of CLL

Visit site